Table 1 Baseline clinical characteristics.
Characteristics—n (%) or mean (SD) | All patients | No ischemia | Ischemia | P value |
|---|---|---|---|---|
105 | 58 (55.2) | 47 (44.8) | ||
Age | 53.2 (15.4) | 54.4 (14.3) | 51 (16.6) | 0.3 |
Male gender | 63 (60) | 37 (63.8) | 26 (55.3) | 0.4 |
Caucasian | 64 (62.5) | 36 (63.2) | 29 (61.7) | 0.6 |
ESC risk | 2.2 (1.3) | 2.3 (1.4) | 2.2 (1.3) | 0.8 |
BMI | 29.9 (5.9) | 30.5 (5.7) | 29.1 (6.1) | 0.2 |
Hypertension | 57 (54.3) | 25 (46.8) | 22 (43.1) | 0.6 |
Diabetes | 11 (10.5) | 9 (15.5) | 2 (4.3) | 0.1 |
Current smoker | 12 (11.4) | 4 (6.9) | 8 (17) | 0.04 |
Chest pain | 17 (16.2) | 10 (17.2) | 7 (14.9) | 0.6 |
Dyspnea | 44 (41.9) | 25 (43.1) | 19 (40.4) | 0.4 |
NYHA class III–IV | 15 (15.4) | 8 (15.1) | 7 (15.9) | 0.6 |
Family history of SCD | 22 (21) | 6 (12.8) | 16 (27.6) | 0.052 |
LVOT gradient > 30 mmHg (*) | 32 (43.8) | 13 (33.3) | 19 (63.3) | 0.01 |
LVOT rest gradient (*) | 35.6 (38.1) | 25.3 (34) | 48.6 (39.5) | 0.01 |
Average 16 segment MPRI | 3.2 (1.4) | 3.9 (1.3) | 2.2 (0.7) | 0.001 |
